Home > 치료사례 > 연구논문
대한약침학회지 제11권 제2호(2008년 6월) 13-19
산삼약침 혈맥주입을 시행한 비소세포성폐암 환자 2례
방선휘1, 귄기록2, 유화승1*
1 대전대학교 한의과대학 둔산한방병원 동서암센터
2 상지대학교 한의과대학 침구학교실
Objectives : To investigate the therapeutic effects of intravenous cultivated wild ginseng(Panax ginseng C.A. Meyer) pharmacopuncture(CWGP) in treating patients with non-small cell lung cancer(NSCLC).
Design : Prospective case series.
Setting : This study was conducted at the East-West Cancer Center of Dunsan Oriental Hospital, Daejeon University.
Patients : Two non-small cell lung cancer patients.
Intervention : Two non-small cell lung cancer patients were injected CWGP(20mL/day) mixed with 0.9% normal saline(100mL) intravenously. Each patient received a total of 16 and 9 cycles, respectively. One cycle is composed of 14 days.
Outcome Measures : The effect of intravenous CWGP was measured by scanning with computed tomography(CT) after every 2 cycle and Positron emission tomography- computed tomography(PET/CT) after every 6 cycles. Response and progression was evaluated using the Response Evaluation Criteria in Solid Tumors(RECIST) Committee classification of complete response(CR), partial response(PR), progressive disease(PD) and stable disease(SD).
Results : They were treated with intravenous CWGP for 8 and 5 months respectively. time later, each tumor remains stable disease(SD)
Conclusion These cases may give us a possibility that intravenous CWGP offers potential benefits for non-small cell lung cancer patients.
key words Intravenous Cultivated Wild Ginseng Pharmacopuncture, Non-Small Cell Lung Cancer :